Address: C76, Balewadi, Pune, Maharashtra
According to a study published by Insure Insights, the global cell analysis system market is expected to grow at a CAGR of 8.9% during the forecast period. Cell analysis is the process of studying the characteristics of cells, including their shape, size, and presence of specific proteins. In addition, it also helps to examine cellular processes such as proliferation and growth. Cell analysis instruments play a vital role in drug development and production. These instruments are employed in various sectors such as pharmaceutical, biotechnology, hospitals, research institutes, and laboratories. The instrument performs several evaluation functions such as cell identification, cell structure studies, cell interaction, cell proliferation, single cell analysis, cell counting, quality control, and cell signaling.
Top Driver: Increasing Chronic Diseases Incidents and Rising Healthcare Expenditure
Attempts for reducing the time and cost involved in drug discovery, increase incidents of chronic diseases such as cancer and diagnostics laboratories, technological innovations, rise in outsourcing of drug discovery services, government initiatives are some of the major factors driving the growth for global cell analysis instruments market. Besides, rising healthcare expenditure and expanding cell-based research activities are expected to fuel the market growth.
On the other hand, the extravagant cost of cell analysis systems and lack of skilled personnel are factors hindering the growth of the global cell analysis system market.
Flow Cytometry Products to Make Crucial Contribution to Growth of Global Cell Analysis System Market
On the basis of product, the market is can be segmented into Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters, HCS Systems, Other Products. The flow cytometry products segment accounted for the largest market share. The growing adoption of flow cytometry products in research and academia, increasing prevalence of chronic diseases and increasing technological advancements could be some major factors anticipating the segment growth. On the basis of process, the market is segmented into Cell Proliferation, Cell Counting and Quality Control, Cell Interaction, Target Identification, Cell Identification, Cell Viability, Cell Signaling Pathways/Signal Transduction, Validation, Single-cell Analysis. On the basis of end use the market is segmented in Research Institutes, Pharmaceutical & Biotechnology Companies and CROs, Hospitals and Diagnostic Laboratories, Cell Culture Collection Repositories, Others.
Rising Investments in Research to Benefit North America Market
North America is estimated to be the largest market for share, followed by Europe. Furthermore, the key factors such as the presence of a favorable business environment, the surge in government support through funds and grants would help the industry propel in the forecast period. The growth in number of research activities coupled with the surge in number of drug discovery initiatives by pharmaceutical & biotechnology companies in the US, and the strong presence of key players in this region are boosting the growth of the market in North America.
Players to Focus on Cell Analysis System Market
The global market is expected to stay fragmented with the increase in the number of new entrants in the coming years. Danaher Corporation, Becton, Dickinson and Company, Merck KGaA, GE Healthcare, Agilent Technologies, Olympus Corporation, Thermo Fisher Scientific, PerkinElmer, Promega Corporation, Tecan Group, Miltenyi Biotec, Carl Zeiss, Bio-Rad Laboratories, Sysmex Corporation, BioStatus Limited, NanoCellect Biomedical, Cell Biolabs, Creative Bioarray, Meiji Techno, and Cytek Biosciences among others could be at the forefront of the competition in the global market.
GE Electric: In December 2019, the European Commission had approved, under the EU Merger Regulation, the proposed acquisition of General Electric’s Healthcare Life Sciences Biopharma Business by Danaher Corporation. The approval is conditional on the divestiture of a remedy package.
BD Life Sciences: In August 2015, BD Life Sciences, a segment of leading global medical technology company BD (Becton, Dickinson and Company) announced it had completed the acquisition of Cellular Research, Inc.
Scope of the Report
By Product
By Process
By End-User
By Region
Key Reasons to Purchase this Report
Table of Content
Chapter 2 Our Research Practice
Chapter 4 Covid-19 Impact Analysis
4.3 Key Factor Impact Analysis
Chapter 5 Global Sepsis Diagnostic Market Forces
5.2 Porter’s Five Forces Analysis
5.2.2 Threats From New Entrants
5.2.4 Threat From Substitute Product
Chapter 6 Global Sepsis Diagnostic Market -Industry Snapshots
6.1.1 Global Sepsis Diagnostic Market Value, 2019 – 2028, (US$ Bn)
6.2.2 Restraint/Challenges analysis
6.3 Supply Chain/Value Chain Analysis
Chapter 7 Global Sepsis Diagnostic Market Analysis, by Technology
7.2 Key Findings for Sepsis Diagnostic Market- By Technology
7.2.1 Sepsis Diagnostic Market- Molecular diagnostic
7.2.2 Sepsis Diagnostic Market- Immunoassay
7.2.3 Sepsis Diagnostic Market- Microbiology
7.2.4 Sepsis Diagnostic Market- Others
Chapter 8 Global Sepsis Diagnostic Market Analysis, by Product
8.2 Key Findings for Sepsis Diagnostic Market- By Product
8.2.1 Sepsis Diagnostic Market- Instruments
8.2.2 Sepsis Diagnostic Market- Assay kits
8.2.3 Sepsis Diagnostic Market- Blood culture media
8.2.4 Sepsis Diagnostic Market- Others
Chapter 9 Global Sepsis Diagnostic Market Analysis, by Diagnostic method
9.2 Key Findings for Sepsis Diagnostic Market- By Diagnostic method
9.2.1 Sepsis Diagnostic Market- Laboratory testing
9.2.2 Sepsis Diagnostic Market- PoC testing
Chapter 10 Global Sepsis Diagnostic Market Analysis, by Pathogen
10.2 Key Findings for Sepsis Diagnostic Market- By Pathogen
10.2.1 Sepsis Diagnostic Market- Fungal sepsis
10.2.2 Sepsis Diagnostic Market- Bacterial sepsis
10.2.3 Sepsis Diagnostic Market- Others
Chapter 11 Sepsis Diagnostic Market Analysis by Region
11.1 Key Findings for Sepsis Diagnostic Market- By region
11.2.1 Global Sepsis Diagnostic Market Analysis, By Technology, 2019 – 2028
11.2.2 Global Sepsis Diagnostic Market Analysis, By Product, 2019 – 2028
11.2.3 Global Sepsis Diagnostic Market Analysis, By Diagnostic method, 2019 – 2028
11.2.4 Global Sepsis Diagnostic Market Analysis, By Pathogen, 2019 – 2028
11.3 Sepsis Diagnostic Market – North America
11.3.5 North America Market, By Technology
11.3.6 North America Market, By Product
11.3.7 North America Market, By Diagnostic method
11.3.8 North America Market, By Pathogen
11.4 Sepsis Diagnostic Market – Europe
11.4.7 Europe Market, By Technology
11.4.8 Europe Market, By Product
11.4.9 Europe market by, Diagnostic method
11.4.10 Europe Market, By Pathogen
11.5 Sepsis Diagnostic Market – Asia Pacific
11.5.6 Asia Pacific Market, By Technology
11.5.7 Asia Pacific Market, By Product
11.5.8 Asia Pacific Market, By Diagnostic method
11.5.9 Asia Pacific Market, By Pathogen
11.6 Sepsis Diagnostic Market – SAMEA
11.6.2 Middle East & Africa (MEA)
11.6.5 South America, Middle East and Africa Market, By Technology
11.6.6 South America, Middle East and Africa Market, By Product
11.6.7 South America, Middle East and Africa Market, By Diagnostic method
11.6.8 South America, Middle East and Africa Market, By Pathogen
Chapter 12 Market Competition Analysis
12.1 Market Share/Positioning Analysis
12.1.1 Market Positioning of Key Vendors, 2019
12.1.2 Key Strategies Adopted by the Leading Players
Chapter 13 Company Profiles- Snapshot
13.3 Becton, Dickinson and Company
13.6 Thermo Fisher Scientific, Inc.
*More than 10 Companies are profiled in this Research Report*
*Financials would be provided on a best efforts basis for private companies”
Please fill out the form to receive sample pages of the report